Could reduced dosing maintain more people on antiretrovirals after the sudden cuts in USAID funding? A crisis response
- PMID: 40265619
- PMCID: PMC12077339
- DOI: 10.1097/QAD.0000000000004212
Could reduced dosing maintain more people on antiretrovirals after the sudden cuts in USAID funding? A crisis response
Abstract
Antiretroviral therapy shortages caused by sudden and severe cuts in USAID and PEPFAR have focused attention on strategies to extend antiretroviral supplies and mitigate this crisis. Efficacy data are now available from seven randomized controlled intermittent triple antiretroviral therapy trials. For countries with urgent drug shortages, this evidence supports intermittent dosing 4-5 days-per-week to extend antiretroviral supplies, with clinical benefits for people living with HIV and continued population benefits of minimizing HIV transmission.
Keywords: AIDS; HIV infection; drug therapy; prevention; resource-limited setting.
Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
There are no conflicts of interest.
References
-
- UNAIDS. UN agency warns of ‘surge’ in AIDS deaths without US funding. UNAIDS website. 24 March 2025. Available at: https://news.un.org/en/story/2025/03/1161416 (Accessed 31 March 2025).
-
- Brink, Debra ten, Martin-Hughes R, Bowring A, Wulan N, Burke K, Tidhar T, et al. . Impact of an international HIV funding crisis on HIV infections and mortality in low-income and middle-income countries: a modelling study. Lancet HIV 2025; [Online ahead of print]. - PubMed
-
- Clinton Health Access Initiative. HIV market impact memo, March 2025.
-
- El-Sadr WM, Lundgren J, Neaton JD, Gordin F, Abrams D, Arduino RC. Strategies for Management of Antiretroviral Therapy (SMART) study group. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med. 2006; 355:2283–96. - PubMed
-
- Ananworanich J, Nuesch R, Le Braz M, Chetchotisakd P, Vibhagool A, Wicharuk S, et al. . Swiss HIV Cohort Study. Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trial. AIDS 2003; 17:F33–F37. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical